Dosage and Administration Because Dihexa has never advanced to human clinical trials, there is no medically established dosing protocol
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor
Potential side effects of GLP-1s include nausea, vomiting, changes in vision, low blood sugar, and, in rare cases, thyroid cancer
Dietary modifications, smaller meals, avoiding high-fat foods, and gradual dose escalation are evidence-based strategies for managing Ozempic's gastrointestinal effects
*Current Pharmaceutical Design*, 26(25), 2953-2962
Stepping back from these forecasts, whose methodology is unclear, these are really big changes in consumer market segments larger than $50B